To evaluate the efficacy of autologous adipose-derived mesenchymal stem cell (ADMSC) therapy on pain, function and disease modification in knee osteoarthritis. 30 participants with symptomatic knee osteoarthritis were randomized into three groups. Two treatment groups received intra-articular ADMSC therapy consisting of either a single injection (100 × 10 ADMSCs) or two injections (100 × 10 ADMSCs at baseline and 6 months). The third group served as control and continued conservative management. No serious adverse events were observed. Both treatment groups receiving ADMSCs showed clinically significant pain and functional improvement at completion of follow-up at 12 months. Radiological analysis using the Magnetic Resonance Imaging Osteoarthritis Knee Score indicated modification of disease progression. Autologous ADMSC therapy appears to be a safe and effective therapy for knee osteoarthritis and may have the potential to prevent disease progression. Trial registration number: ACTRN12614000814673.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.2217/rme-2018-0161 | DOI Listing |
J Exp Orthop
January 2025
Department of Orthopedics, Balgrist University Hospital University of Zurich Zurich Switzerland.
Purpose: The goals of this study were (1) to assess whether the preoperative difference between modalities and extent of deformity are associated with a higher difference between planned and achieved surgical correction and (2) if they yield a higher probability of intraoperative adjustments.
Methods: Retrospective single-centre analysis of patients undergoing patient-specific instrumented (PSI) total knee arthroplasty (TKA). Preoperative radiographic parameters were analysed on weightbearing (WB) long-leg radiographs (LLR) and nonweightbearing (NWB) computed tomography (CT).
Osteoarthr Cartil Open
March 2025
Biosplice Therapeutics, 9360 Towne Center Dr., San Diego, CA, 92121, USA.
Health Qual Life Outcomes
December 2024
Centre for Outcomes Research and Evaluation, McGill University Health Centre-Research Institute, Montreal, QC, Canada.
Background: Health-related quality of life (HRQL) is an important endpoint when evaluating the effectiveness of interventions in people living with hip and knee osteoarthritis (OA). The aim of this study was to generate domains for a new OA-specific preference-based index of HRQL in people living with hip or knee OA.
Methods: The proposed HRQL index was based on a formative measurement model.
BMC Musculoskelet Disord
December 2024
Department of Orthopedics, Shanghai Tenth People's Hospital, Tongji University School of Medicine, 301 Yanchang Rd, Shanghai, 200072, People's Republic of China.
Background: The study aimed to explore whether Miya (MY), a kind of Clostridium butyricum, regulated osteoarthritis (OA) progression through adenosine 5'-monophosphate-activated protein kinase (AMPK) pathway.
Methods: The OA rats were orally given MY daily for 4 weeks and were intramuscularly injected with AMPK inhibitor once a week for 4 weeks. Hematoxylin eosin (HE) staining was used to observe the histological morphology of the knee joint.
BMC Musculoskelet Disord
December 2024
Department of Orthopedics, The Second Affiliated Hospital of Air Force Military Medical University (Tangdu Hospital), 569 Xinsi Road, Baqiao District, Xi'an City, Shaanxi Province, 710000, China.
Objective: To explore the relationship between meniscus compression and the severity of knee osteoarthritis.
Materials And Methods: A retrospective case-control study included 95 patients with knee osteoarthritis (OA) admitted to our hospital from April 2021 to July 2023, who were grouped into slight protrusion of meniscus group (n = 48) and severe protrusion of meniscus group (n = 47) according to the degree of meniscal extrusion. Various parameters, including Kellgren/Lawrence classification, imaging findings, cartilage damage grading, physical function assessments, and correlation analyses, were used to evaluate the relationship between meniscal extrusion and disease progression.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!